| Drug Name: | Hydrogen Peroxide (7722-84-1) |
|---|---|
| PubChem ID: | 784 |
| SMILES: | OO |
| InchiKey: | MHAJPDPJQMAIIY-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Infective Agents, Noxae, Oxidants |
| Molecular Weight (dalton) | : | 34.014 |
| LogP | : | 0.0174 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 40.46 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Endow Cancer Cells With Resistance | Peroxiredoxin-2 (P32119) | Peroxiredoxin II endow cancer cells with resistance to both H202 and cisplatin and to grant them radioresistance [ ADR Type 2 ] | Synergistic effect of peroxiredoxin II antisense on cisplatin-induced cell death |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category